Farmavip Pharmaceuticals started its operations in 2004 with 20 years of sectoral experience. The company, which carries out pharmaceutical R&D studies and licensing activities, put its first product, PENFLOKS 500 mg Film Tablet, and many products in different treatment fields, into the service of Turkish medicine in 2020. The company, which also has license studies with different content, will launch four more drugs in 2022. Collaborating with the world’s leading companies with raw materials and finished products, Farmavip İlaç’s goal is to provide innovative product services to patients in the easiest, safest and fastest way within the framework of ethical and scientific values. Licensing processes for many pharmaceutical products continue. Our biggest goal is to be a company that has achieved significant success and services in this field by expanding its product portfolio.

OUR MISSION

Our founding purpose as Farmavip İlaç; is to keep human health as the first priority. By fulfilling all the requirements of human health; To provide a service that increases and maintains its sustainable growth in the global market, is preferred with its competitive power, and most importantly, is trusted.

OUR VISION

The experience, trust, high quality culture and dynamism we have in the Turkish pharmaceutical industry; to develop innovative products by bringing innovation together with innovation, to touch the lives of more people, to work for the benefit of our country, the society and the world we live in. Farmavip Pharmaceuticals is an innovative company that aims to benefit the individual and therefore public health, knows its sector well, aims to add value to the country’s economy, and combines the creation of inspiring brands with manpower and technology.